Market Highlights: Oral contraceptive drugs are is pill used to prevent unwanted pregnancy by blocking the normal process of ovulation or by altering the process which supports the fertilization of an egg. Pills include progestin and estrogen hormones. The market for birth control pills is increasing owing to the growing need for population control and increasing incidents of abortion. The market study is being classified by Type (Long-acting Contraceptives, Short-acting Contraceptives and Emergency Contraceptives), by Application (Hospital, Pharmacy and Other) and major geographies with country level break-up that includes South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Key Players: The prominent players in the Oral Contraceptive Drugs are Merck (United States), Pfizer (United States), Teva Pharmaceutical (Israel), Actavis (United States), Johnson & Johnson (United States), Gedeon Richter (Hungary) and Novo Nordisk A/S (Denmark).
Major Market Development Highlights In July 2019, Lyndra Therapeutics (the US), a leading pharmaceutical product company, announced the receiving of USD 13 MN grant from Bill and Melinda Gates Foundation toward the development of a once-a-month oral contraceptive
Key Questions Answered in the Report What will the Oral Contraceptive Drugs Market size and the growth rate be in Future? What are the key factors driving the Oral Contraceptive Drugs Market? What are the key market trends and macro-economic impacting the growth of the Oral Contraceptive Drugs Market? What are the challenges to market growth? Who are the key vendors in the Oral Contraceptive Drugs Market? What are the market opportunities and threats faced by the vendors in the Oral Contraceptive Drugs Market? Trending factors influencing the market shares of the Players. What are the key outcomes of the five forces analysis of the Oral Contraceptive Drugs Market?
Research Methodology: The top-down and bottom-up approaches are used to estimate and validate the size of the Global Oral Contraceptive Drugs market. In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Oral Contraceptive Drugs market. In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc. Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Oral Contraceptive Drugs Manufacturer, Government and Investment Communities, Research Organization and Associations and Others. This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth etc. Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.